Gerard Fenton Anderson
#124,305
Most Influential Person Now
Gerard Fenton Anderson's AcademicInfluence.com Rankings
Gerard Fenton Andersonmedical Degrees
Medical
#1956
World Rank
#2344
Historical Rank
Public Health
#276
World Rank
#285
Historical Rank
Epidemiology
#326
World Rank
#343
Historical Rank
Download Badge
Medical
Why Is Gerard Fenton Anderson Influential?
(Suggest an Edit or Addition)Gerard Fenton Anderson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. (2004) (3409)
- Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. (2002) (2112)
- Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. (2003) (764)
- It's the prices, stupid: why the United States is so different from other countries. (2003) (591)
- The Growing Burden of Chronic Disease in America (2004) (507)
- Population aging: a comparison among industrialized countries. (2000) (485)
- The relation between funding by the National Institutes of Health and the burden of disease. (1999) (474)
- Out-of-pocket medical spending for care of chronic conditions. (2001) (412)
- The Relationship Between a Dementia Diagnosis, Chronic Illness, Medicare Expenditures, and Hospital Use (2004) (370)
- U.S. health care spending in an international context. (2004) (345)
- Hospital readmissions in the Medicare population. (1984) (337)
- National Outcomes of Cataract Extraction: Retinal Detachment and Endophthalmids after Outpatient Cataract Surgery (1991) (318)
- Postdischarge environmental and socioeconomic factors and the likelihood of early hospital readmission among community-dwelling Medicare beneficiaries. (2008) (305)
- Chronic Medical Illness, Depression, and Use of Acute Medical Services Among Medicare Beneficiaries (2004) (264)
- Health spending in the United States and the rest of the industrialized world. (2005) (248)
- Health care spending and use of information technology in OECD countries. (2006) (240)
- Inpatient hospital admission and death after outpatient surgery in elderly patients: importance of patient and system characteristics and location of care. (2004) (226)
- Diabetes-related morbidity and mortality in a national sample of U.S. elders. (2002) (222)
- The content and cost of cataract surgery. (1993) (219)
- Uncertain Demand, the Structure of Hospital Costs, and the Cost of Emptyhospital Beds (1993) (218)
- Using electronic health records to help coordinate care. (2004) (215)
- Comorbidity and the Use of Primary Care and Specialist Care in the Elderly (2005) (209)
- Expanding priorities--confronting chronic disease in countries with low income. (2007) (209)
- Expenditures for care of children with chronic illnesses enrolled in the Washington State Medicaid program, fiscal year 1993. (1997) (203)
- Health spending, access, and outcomes: trends in industrialized countries. (1999) (196)
- International applicability of the VF-14. An index of visual function in patients with cataracts. (1997) (191)
- How does the quality of care compare in five countries? (2004) (190)
- Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016 (2018) (188)
- Cross-national comparisons of health systems using OECD data, 1999. (2002) (179)
- Risk-Adjusted Medicare Capitation Rates Using Ambulatory and Inpatient Diagnoses (1996) (179)
- Health spending in OECD countries: obtaining value per dollar. (2008) (174)
- Multiple Chronic Conditions and Life Expectancy: A Life Table Analysis (2014) (169)
- Comparing Health System Performance In OECD Countries (2001) (164)
- More Training Needed in Chronic Care: A Survey of U.S. Physicians (2004) (158)
- Effect of Postoperative Epidural Analgesia on Morbidity and Mortality Following Surgery in Medicare Patients (2004) (154)
- Choices for Healthy Outcomes In Caring for End Stage Renal Disease (1996) (151)
- From 'soak the rich' to 'soak the poor': recent trends in hospital pricing. (2007) (141)
- Extreme Markup: The Fifty US Hospitals With The Highest Charge-To-Cost Ratios. (2015) (138)
- Measuring financial protection in health in the United States. (2004) (138)
- Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the medicare population. (1999) (135)
- Downsizing the hospital nursing workforce. (1996) (134)
- Medicare and chronic conditions. (2005) (134)
- High-Need, High-Cost Patients: Who Are They and How Do They Use Health Care? A Population-Based Comparison of Demographics, Health Care Use, and Expenditures. (2016) (132)
- Health spending and outcomes: trends in OECD countries, 1960-1998. (2000) (129)
- Risk of endophthalmitis after cataract extraction: results from the International Cataract Surgery Outcomes study (1997) (127)
- Predicting hospital readmissions in the Medicare population. (1985) (119)
- Newly Reported Chronic Conditions and Onset of Functional Dependency (2005) (119)
- Preventable hospitalization among elderly Medicare beneficiaries with type 2 diabetes. (2003) (118)
- Protecting children with chronic illness in a competitive marketplace. (1995) (117)
- Utilization of medical and health-related services among school-age children and adolescents with special health care needs (1994 National Health Interview Survey on Disability [NHIS-D] Baseline Data). (2003) (108)
- Capitation, managed care, and chronic obstructive pulmonary disease. (1998) (103)
- Considering long-term care insurance for middle-income countries: comparing South Korea with Japan and Germany. (2015) (103)
- It's Still The Prices, Stupid: Why The US Spends So Much On Health Care, And A Tribute To Uwe Reinhardt. (2019) (102)
- A comparison of single- and multi-payer health insurance systems and options for reform. (2003) (101)
- Alzheimer's Disease Under Managed Care: Implications from Medicare Utilization and Expenditure Patterns (1998) (100)
- Higher Hospital Spending on Occupational Therapy Is Associated With Lower Readmission Rates (2017) (97)
- A More Detailed Understanding Of Factors Associated With Hospital Profitability. (2016) (97)
- Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs. (2013) (89)
- Noncommunicable chronic disease in Bangladesh: overview of existing programs and priorities going forward. (2011) (87)
- Accuracy of Medicare Claims Data for Estimation of Cancer Incidence and Resection Rates Among Elderly Americans (1991) (85)
- Health spending in OECD countries in 2004: an update. (2007) (85)
- Do quality improvement organizations improve the quality of hospital care for Medicare beneficiaries? (2005) (82)
- Risk Reduction From Low Osmolality Contrast Media: What Do Patients Think It is Worth? (1990) (81)
- Mortality after elective total hip arthroplasty in elderly Americans. Age, gender, and indication for surgery predict survival. (1993) (80)
- Willingness to pay to shorten waiting time for cataract surgery. (1997) (79)
- In search of value: an international comparison of cost, access, and outcomes. (1997) (74)
- Patterns of Expenditures and Use of Services Among Older Adults With Diabetes: Implications for the transition to capitated managed care (1998) (74)
- Visual outcomes of cataract surgery in the United States, Canada, Denmark, and Spain. Report From the International Cataract Surgery Outcomes Study. (1998) (73)
- Multinational Comparisons of Health Systems Data, 2008 (2000) (73)
- Health Care Cost Containment (1990) (71)
- Health Insurers' Assessment of Medical Necessity (1992) (70)
- Do hospitals provide lower-quality care to minorities than to whites? (2008) (67)
- Effect of Postoperative Epidural Analgesia on Morbidity and Mortality After Total Hip Replacement Surgery in Medicare Patients (2003) (66)
- Impact of Claims Data Research on Clinical Practice (1990) (65)
- Visual functional outcomes of cataract surgery in the United States, Canada, Denmark, and Spain: Report of the International Cataract Surgery Outcomes Study (2003) (63)
- Patients' acceptance of waiting for cataract surgery: what makes a wait too long? (1997) (63)
- Use of Medicare claims data to evaluate outcomes in elderly patients undergoing lung resection for lung cancer. (1991) (61)
- US Hospitals Are Still Using Chargemaster Markups To Maximize Revenues. (2016) (60)
- Physician, public, and policymaker perspectives on chronic conditions. (2003) (59)
- Variation in indications for cataract surgery in the United States, Denmark, Canada, and Spain: results from the International Cataract Surgery Outcomes Study (1998) (57)
- Development of clinical and economic prognoses from Medicare claims data. (1990) (56)
- The relationship between per capita income and diffusion of medical technologies. (2001) (54)
- Results of colectomy in elderly patients with colon cancer, based on Medicare claims data. (1992) (53)
- In Japan, all-payer rate setting under tight government control has proved to be an effective approach to containing costs. (2012) (51)
- Effect of recombinant erythropoietin on hospital admissions, readmissions, length of stay, and costs of dialysis patients. (1994) (50)
- To buy or not to buy. Technology acquisition under prospective payment. (1984) (50)
- Capitation adjustment for pediatric populations. (1996) (49)
- Setting payment rates for capitated systems: a comparison of various alternatives. (1990) (48)
- The likely economic impact of fewer elective surgical procedures on US hospitals during the COVID-19 pandemic (2020) (47)
- International Programme for Resource Use in Critical Care (IPOC) – a methodology and initial results of cost and provision in four European countries (2006) (44)
- Technology coverage decisions by health care plans and considerations by medical directors. (1997) (42)
- The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities. (1994) (41)
- Cost-effectiveness of extracorporeal shock-wave lithotripsy versus cholecystectomy for symptomatic gallstones. (1991) (41)
- Universal health care coverage in Korea. (1989) (40)
- Trends in socioeconomic disparities in health care quality in four countries. (2007) (40)
- International variation in anesthesia care during cataract surgery: results from the International Cataract Surgery Outcomes Study. (1997) (40)
- Perioperative risk: how can we study the influence of provider characteristics? (2002) (40)
- Health insurance coverage in Central and Eastern Europe: trends and challenges. (2008) (40)
- Economic impact of immunization against rotavirus gastroenteritis. Evidence from a clinical trial. (1995) (39)
- The Costs of Children With Sickle Cell Anemia: Preparing for Managed Care (1998) (39)
- Predicting expenditures for Medicare beneficiaries with diabetes. A prospective cohort study from 1994 to 1996. (1999) (38)
- Comparing the Value of Nonprofit Hospitals’ Tax Exemption to Their Community Benefits (2018) (38)
- DRGs and specialized nutrition support. Prospective payment and nutritional support: the need for reform. (1986) (37)
- Variation in the Ratio of Physician Charges to Medicare Payments by Specialty and Region (2017) (37)
- Factors influencing third party payer costs for allogeneic BMT. (1993) (36)
- US pharmaceutical innovation in an international context. (2010) (36)
- Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval. (1992) (35)
- Medical technology assessment and practice guidelines: their day in court. (1993) (34)
- Early dosing practices and effectiveness of recombinant human erythropoietin. (1993) (33)
- Doughnut holes and price controls. (2004) (32)
- Analyzing Health Outcomes Through International Comparisons (1994) (30)
- Hospice Care and Resource Utilization in Medicare Beneficiaries With Heart Failure (2011) (30)
- Variations in cataract management: patient and economic outcomes. (1990) (29)
- Implications of medicare's prospective payment system for specialized nutrition services (1986) (29)
- Hospital Costs and the Cost of Empty Hospital Beds (1991) (28)
- Effect of cost-sharing reductions on preventive service use among Medicare fee-for-service beneficiaries. (2012) (28)
- Measuring the U.S. health care system: a cross-national comparison. (2010) (28)
- Capitation pricing: Adjusting for prior utilization and physician discretion (1986) (28)
- Cost and procedure implications of thrombolytic therapy for acute myocardial infarction. (1988) (28)
- Missing in action: international aid agencies in poor countries to fight chronic disease. (2009) (27)
- Varying Trends In The Financial Viability Of US Rural Hospitals, 2011-17. (2020) (26)
- Comorbidity and Outcomes of Coronary Artery Bypass Graft Surgery at Cardiac Specialty Hospitals Versus General Hospitals (2007) (26)
- Health System Performance for the High-Need Patient: A Look at Access to Care and Patient Care Experiences. (2016) (26)
- Hospital employment trends in California, 1982-1994. (1996) (26)
- Variation in Emergency Department vs Internal Medicine Excess Charges in the United States (2017) (26)
- Comparison of risk adjusters for medicaid-enrolled children with and without chronic health conditions. (2001) (25)
- Achieving universal health insurance in Korea: a model for other developing countries? (1992) (25)
- Spending on medical care: more is better? (2008) (24)
- Health and Population Aging: A Multinational Comparison (1999) (24)
- Is cost containment working? (1985) (24)
- PPE Supply Chain Needs Data Transparency and Stress Testing (2020) (24)
- Analysis Suggests Government And Nonprofit Hospitals' Charity Care Is Not Aligned With Their Favorable Tax Treatment. (2021) (23)
- Pediatric carve outs. The use of disease-specific conditions as risk adjusters in capitated payment systems. (1997) (23)
- The latest disease burden challenge: People with multiple chronic conditions (2011) (22)
- Do Minority Patients Use Lower Quality Hospitals? (2011) (22)
- The courts and health policy: strengths and limitations. (1992) (21)
- Bridging the Silos of Service Delivery for High-Need, High-Cost Individuals. (2016) (21)
- Incorporating New Research Into Medicare Risk Adjustment (2011) (21)
- Continuity of Care and Its Effect on Prescription Drug Use Among Medicare Beneficiaries With Hypertension (2011) (21)
- Role of the FDA in Affordability of Off-Patent Pharmaceuticals. (2016) (21)
- Paying for HMO care: issues and options in setting capitation rates. (1986) (20)
- The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients (1994) (20)
- Economic implications of decreased elective orthopaedic and musculoskeletal surgery volume during the coronavirus disease 2019 pandemic (2020) (20)
- Methods of reducing the financial risk of physicians under capitation. (1999) (19)
- Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography. (1993) (19)
- International Variation in Ophthalmologic Management of Patients With Cataracts Results From the International Cataract Surgery Outcomes Study (1997) (19)
- Academic health centers: exploring a financial paradox. (1999) (19)
- All-payer ratesetting: Down but not out (1992) (18)
- Allocation of National Institutes of Health Funding by Disease Category in 2008 and 2019 (2021) (18)
- Medicare Payment Reform: Aligning Incentives for Better Care. (2015) (18)
- Medicare beneficiaries most likely to be readmitted. (2013) (18)
- Financial Eligibility Criteria and Medication Coverage for Independent Charity Patient Assistance Programs. (2019) (17)
- Potential "losers" under per-case payment. (1987) (17)
- Use of low-osmolality contrast media in a price-sensitive environment. (1988) (17)
- Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing (2018) (17)
- Relationship between continuity of care and adverse outcomes varies by number of chronic conditions among older adults with diabetes (2016) (16)
- What does not explain the variation in the direct costs of graduate medical education (1996) (16)
- Comparing health system performance in OECD countries. Organization for Economic Cooperation and Development. (2001) (16)
- International variation in ophthalmologic management of patients with cataracts. Results from the International Cataract Surgery Outcomes Study. (2007) (16)
- Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study (2020) (16)
- An Economic Interpretation of the Medieval Crusades (1992) (15)
- Graduate medical education: the policy debate. (2001) (15)
- Providing Hospital Services: The Changing Financial Environment (1989) (15)
- Eliminating drug price differentials across government programmes in the USA (2010) (15)
- Medicare payment policy and recombinant erythropoietin prescribing for dialysis patients. (1993) (15)
- Charity Care Provision by US Nonprofit Hospitals. (2020) (15)
- Predictors of Health Resource Use by Disabled Older Female Medicare Beneficiaries Living in the Community (2003) (15)
- Multinational Comparisons of Health Care: Expenditures, Coverage, and Outcomes (1998) (14)
- Remote Management Improves Icu Outcomes (1999) (14)
- Patient Selection After Mandatory Bundled Payments for Hip and Knee Replacement: Limited Evidence of Lemon-Dropping or Cherry-Picking. (2019) (14)
- Comparative Approaches to Drug Pricing. (2019) (14)
- Addressing Generic-Drug Market Failures - The Case for Establishing a Nonprofit Manufacturer. (2018) (14)
- Market Power: Price Variation Among Commercial Insurers For Hospital Services. (2018) (14)
- Comparative Renoprotective Effect of Febuxostat and Allopurinol in Predialysis Stage 5 Chronic Kidney Disease Patients: A Nationwide Database Analysis (2019) (13)
- Maryland: A Regulatory Approach to Health System Reform (1993) (13)
- Air Ambulances With Sky-High Charges. (2019) (13)
- Coverage Decisions for Medical Technology by Managed Care: Relationship to Organizational and Physician Payment Characteristics (1996) (13)
- Using External Reference Pricing In Medicare Part D To Reduce Drug Price Differentials With Other Countries. (2019) (13)
- The effect of income taxation on the demand for employer-provided health insurance (1984) (13)
- "Carving out" conditions from global capitation rates: protecting high-cost patients, physicians, and health plans in a managed care environment. (1998) (13)
- A Review of the First Year of Medicare Coverage of Erythropoietin (1994) (12)
- Variations in life expectancy in Organization for Economic Co-operation and Development countries – 1985–2010 (2015) (12)
- Medicare prescription drug coverage gap: navigating the "doughnut hole" with patients. (2007) (12)
- Biosimilar Uptake in Medicare Part B Varied Across Hospital Outpatient Departments and Physician Practices: The Case of Filgrastim. (2020) (12)
- Special issues with single-payer health insurance systems (2004) (12)
- The review process used by U.S. health care plans to evaluate new medical technology for coverage (1996) (12)
- Investor-owned chains and teaching hospitals. The implications of acquisition. (1985) (11)
- Population Aging : A Comparison Among Industrialized Countries Populations around the world are growing older , but the trends are not cause for despair (2001) (11)
- Pharmaceutical Industry Support of US Patient Advocacy Organizations: An International Context (2019) (11)
- Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available. (2019) (11)
- Diagnosis related group prospective payment: implications for health care and medical technology. (1984) (10)
- The All-Payer Rate Setting Model for Pricing Medical Services and Drugs. (2015) (10)
- Reducing Branded Prescription Drug Prices: A Review of Policy Options (2017) (10)
- Life Expectancy in 2040: What Do Clinical Experts Expect? (2016) (10)
- National medical care spending. (1985) (10)
- Reevaluating "made in America"--two cost-containment ideas from abroad. (2013) (9)
- Limited distribution networks stifle competition in the generic and biosimilar drug industries. (2018) (9)
- Awareness of Providers' Use of New Medical Technology Among Private Health Care Plans in the United States (1996) (9)
- Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US (2020) (8)
- Specialty of principal care physician and Medicare expenditures in patients with coronary artery disease: impact of comorbidity and severity. (2001) (8)
- Evaluating Clinical Practice Guidelines Based on Their Association with Return to Work in Administrative Claims Data. (2016) (8)
- Targeting High-Need Beneficiaries in Medicare Advantage: Opportunities to Address Medical and Social Needs. (2019) (8)
- The impact of practice guidelines on opioid utilization for injured workers (2017) (8)
- Characteristics of Copayment Offsets for Prescription Drugs in the United States. (2021) (8)
- Hospital expenditures and utilization: the impact of HMOs. (1999) (8)
- Leadership in Creating Accountable Care Organizations (2011) (8)
- Examining the Relationship between Capital Investment and Hospital Operating Expenditures (1987) (8)
- Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study (2020) (8)
- Spurring new research for neglected diseases. (2009) (8)
- Consumer Responses to Price Disclosure in Direct-to-Consumer Pharmaceutical Advertising (2019) (7)
- Capitation payment rates and implications for the general pediatrician. (1998) (7)
- Capitation for cardiologists: accepting risk for coronary artery disease under managed care. (1998) (7)
- Access to Antihypertensive Drugs in China. (2018) (7)
- When courts review medical appropriateness. (1998) (7)
- Employment trends in hospitals, 1981-1993. (1996) (6)
- Nurse practitioners and physician assistants in emergency medical services who billed independently, 2012–2016☆ (2019) (6)
- Medicare's Prospective Payment System: The Victim of Aggregation Bias? (1992) (6)
- Reducing the cost of using contrast media: a look at discarded volumes. (1988) (6)
- Changes in CT utilization between 1981 and 1984: implications for Medicare payment for MR imaging under the prospective payment system. (1987) (6)
- The National Commission on Physician Payment Reform: Recalibrating Fee-for-Service and Transitioning to Fixed Payment Models (2014) (6)
- The role of investment bankers in nonprofit conversions. (1997) (6)
- Health Systems in Industrialized Countries (2011) (6)
- National medical care spending. (1986) (6)
- Public support for policies that would help people with chronic conditions. (2002) (6)
- COVID-19 and Hospital Financial Viability in the US (2022) (6)
- Pharmaceutical Industry Funding to Patient-Advocacy Organizations: A Cross-National Comparison of Disclosure Codes and Regulation (2019) (5)
- Geographic Variability of Adherence to Occupational Injury Treatment Guidelines (2014) (5)
- Modifying the Criteria for Granting Orphan Drug Market Exclusivity. (2020) (5)
- Medical Malpractice and the US Health Care System (2007) (5)
- Planned readmissions: a potential solution. (2012) (5)
- Assessing the Added Therapeutic Benefit of Ultra-Expensive Drugs. (2021) (5)
- A surplus of physicians in Israel: any lessons for the United States and other industrialized countries? (1991) (5)
- National medical care spending. (1987) (5)
- Medicare part D: ongoing challenges for doctors and patients. (2010) (5)
- Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States (2020) (5)
- Branded prescription drug spending: a framework to evaluate policy options (2017) (5)
- The adequacy of hospital reimbursement under Medicaid's Boren Amendment. (1992) (5)
- Comparing Health System Performance In OECD Countries Cross-national comparisons can determine whether additional health care spending results in better outcomes. (2001) (4)
- Non-communicable diseases and injuries in Eastern Europe and Eurasia (2006) (4)
- Health Care Spending in OECD Countries: Obtaining Value per Dollar (2008) (4)
- Predictors of orphan drug coverage restrictions in Medicare Part D. (2020) (4)
- The States as Important Laboratories for Federal Prescription Drug Cost-Containment Efforts (2019) (4)
- Premature adult mortality from non-communicable diseases (NCD) in three middle-income countries: do NCD programmes matter? (2012) (4)
- TEACHING HOSPITALS IN THE USA: INSTITUTIONS UNDER STRESS? (1987) (4)
- High US Health-Care Spending and the Importance of Provider Payment Rates (2012) (3)
- Improving regional variation using quality of care measures (2009) (3)
- Variable Market Exclusivity Periods for Pharmaceuticals (2016) (3)
- Non-Communicable Chronic Diseases: Winning on Facts but Losing on Passion (2015) (3)
- Do mergers and acquisitions improve firms' financial performance? The case of the U.S. generic drug industry (2019) (3)
- Pediatric carve outs (1997) (3)
- MEDICARE EXPENDITURES FOR BENEFICIARIES WITH DEMENTIA OF THE ALZHEIMER'S TYPE (1999) (3)
- Monitoring hospital readmissions. (1989) (3)
- Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry (2018) (3)
- Participation, Pricing, and Enrollment in a Health Insurance "Public Option": Evidence From Washington State's Cascade Care Program. (2021) (3)
- Measuring Nonprofit Hospitals' Provision of Charity Care Using IRS and CMS Data. (2019) (3)
- Perspective: The Role Of Investment Bankers (1997) (3)
- State regulation of managed care: the impact on children. (1998) (3)
- Biosimilar formulary placement in Medicare Part D prescription drug plans: A case study of infliximab. (2020) (2)
- Comparative health systems (2010) (2)
- Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006–2016 (2020) (2)
- Health Insurance Exchanges (2009) (2)
- Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program (2021) (2)
- Trends Health Insurance Coverage In Central And Eastern Europe : Trends And Challenges (2008) (2)
- Controlling U.S. health spending: opportunities for academic health centers. (2006) (2)
- Association Between Waste-Free Formularies and Prescription Drug Spending Among Self-insured Employers (2021) (2)
- Off-Label Coverage of High-Cost Drugs by Independent Charity Patient Assistance Programs (2020) (2)
- MarketWatch From ‘ Soak The Rich ’ To ‘ Soak The Poor ’ (2007) (2)
- Comparing patient OOP spending for specialty drugs in Medicare Part D and employer-sponsored insurance. (2020) (2)
- Comparison of Trends in Nonprofit Hospitals’ Charity Care Eligibility Policies Between Medicaid Expansion States and Medicaid Nonexpansion States (2021) (2)
- Comparison of price, volume and composition of services provided to inpatients for two procedures between a US and a Japanese academic hospital (2013) (2)
- Naming Convention, Interchangeability, and Patient Interest in Biosimilars (2020) (2)
- Increasing frequency and share of dermatologic procedures billed by nonphysician clinicians from 2012 to 2016 (2018) (2)
- Health plan options at fortune 100 companies: available coverage for mental health care consumers. (2003) (2)
- Effective Medical Leadership (2011) (2)
- State Efforts to Lower Health Care Prices Paid by Private Insurers. (2019) (2)
- Safety of Outpatient Surgery in the Elderly: The Importance of the Patient, System and Location of Care: [2002][A-1127] (2002) (2)
- Achieving universal coverage through Medicare Part E(veryone) (2007) (2)
- Pharmaceutical 'Pay-for-Delay' Reexamined: A Dwindling Practice or a Persistent Problem? (2019) (1)
- The effects of payment by results (2009) (1)
- Pioglitazone is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006-2016 (2020) (1)
- A Non-Profit Approach to Address Foreign Dependence of Generic Drugs (2021) (1)
- Comparative Health Care Spending for Dialysis: An Example of Public Cost Containment? (2021) (1)
- Nursing supply through an international lens (2003) (1)
- The Impact of Adherence to Clinical Practice Guidelines on Medical Costs. (2020) (1)
- A decomposition analysis of medical expenditure growth among injured workers. (2013) (1)
- Cost-effectiveness of total state coverage for hepatitis C medications. (2021) (1)
- Complex Patients and Quality of Care in Medicare Advantage (2020) (1)
- Questioning the need to ration Heinz Redwood Why Ration (2001) (1)
- Payment reform in the United States. (1986) (1)
- Site-Based Payment Differentials for Ambulatory Services among Individuals with Commercial Insurance. (2022) (1)
- PNS110 CONSOLIDATED DRUG PURCHASING ACROSS FEDERAL AGENCIES: A SOLUTION TO IMPROVE DRUG AFFORDABILITY IN MEDICARE PART D (2019) (1)
- Factors Associated With Manufacturer Drug Coupon Use at US Pharmacies (2021) (1)
- Medicare's Prospective Payment System: Paying for Magnetic Resonance Imaging (1986) (1)
- Physician Charges and Medicare Payments. (2017) (1)
- Are Teaching Hospitals Thriving? The Authors Respond (1999) (1)
- Hospital Inpatient Charges of COVID-19 Diagnostic Tests Ranged from $10 to $1390. (2020) (1)
- Ultra-Expensive Drugs And Medicare Part D: Spending And Beneficiary Use Up Sharply. (2021) (1)
- Long-Term Care Worker Shortage (2008) (1)
- Labor Market Concentration and Worker Contributions to Health Insurance Premiums (2021) (1)
- Relationship between continuity of care and adverse outcomes varies by number of chronic conditions among older adults with diabetes (supplementary file) (2016) (1)
- Fairness in drug prices: do economists think differently from the public? (2018) (1)
- Investment Income of US Nonprofit Hospitals in 2017 (2020) (1)
- Mental Health Parity (2009) (1)
- MEETING LONG-TERM CARE NEEDS (2004) (1)
- Commentary on Gross and Laugesen (2018) (0)
- The Impact of Adherence to Clinical Practice Guidelines on Medical Costs. (2020) (0)
- From Other Countries It's The Prices, Stupid: Why The United States Is So Different (2014) (0)
- Choosing an electronic medical record (2004) (0)
- Quality Improvement Organizations and Hospital Care—Reply (2005) (0)
- Correction to: Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States (2021) (0)
- Competition And Vulnerabilities In The Global Supply Chain For US Generic Active Pharmaceutical Ingredients. (2023) (0)
- Health Savings Accounts - An Update (2008) (0)
- Incorporating Ethics in Policy Change and Health Reform (2019) (0)
- The Courts and Health Policy: The Author Responds (1992) (0)
- International Differences: The Authors Respond (2005) (0)
- Is the Orphan Drug Act Being used as a Loophole to Extend Periods of Drug Exclusivity (2018) (0)
- Hospitals with Higher Direct Cost Ratios Have Lower Readmission Rates (2017) (0)
- Health care payment reform. Projections for the next 15 years. (1985) (0)
- For hospitals, productivity, technology are key. Interview by Michele Robinson. (1988) (0)
- THE COMMONWEALTH FUND 2007-08 HARKNESS FELLOWSHIPS IN HEALTH CARE POLICY AND PRACTICE ORIENTATION SEMINAR PARTICIPANT CONTACT LIST (2007) (0)
- PMU72 - ESTIMATED COSTS OF PIVOTAL TRIALS FOR NOVEL THERAPEUTIC AGENTS APPROVED BY THE FDA, 2015-2016 (2018) (0)
- INCREASING MALPRACTICE INSURANCE RATES: BLAME THE LAWYERS OR THE STOCK MARKET? (2003) (0)
- Comorbidity increases health care expenditures and physician utilization in elderly patients with chronic heart failure (2003) (0)
- Health Affairs 2004 International Issue: Global Views on Costs, Access, and Quality (2004) (0)
- Public Health & Policy (2003) (0)
- 8 Variation in Emergency Department Pricing in the United States (2016) (0)
- Abandoning List Prices In Medicaid Drug Reimbursement Did Not Affect Spending. (2020) (0)
- A 2002 survey conducted by Medical Liability Monitor contained the following highlights: in 2002, malpractice premiums for internists and general surgeons increased by an average of 25%, and rates for obstetricians and gynecol- (2003) (0)
- Anticipating Reforms to the Prescription Drug User Fees Act. (2022) (0)
- Hospital reorganization: examining the effects on medical education. (1987) (0)
- Differences between cardiologists and generalists in ischemic heart disease expenditures for medicare managed care (1998) (0)
- Medicare reform. (2001) (0)
- Academic Health Centers: Exploring A Financial (1999) (0)
- DRGs and hospital readmissions. (1985) (0)
- The Relationships Among Cash Prices, Negotiated Rates, And Chargemaster Prices For Shoppable Hospital Services. (2023) (0)
- TWO ESSAYS IN HEALTH CARE - ALLOCATION OF RESOURCES AND HEALTH HABIT FORMATION (1980) (0)
- Spending on Medical Care (2017) (0)
- All-payer ratesetting: down but not out. (1991) (0)
- Reply to Comment on “Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US” (2020) (0)
- Payment reform's impact on quality of hospital products. (1988) (0)
- of NBER's research program in Health Economics. Any opinions expressed are those of the (1991) (0)
- Means-testing in Medicare (2007) (0)
- The Role of Advance Purchasing Commitments in Government Drug Price Negotiations: Lessons From the COVID-19 Response. (2021) (0)
- When States Mandate Hospital Community Benefit Reports, Provision Increases (2023) (0)
- PSY128 - HOW LONG CAN THE ORPHAN DRUG EXCLUSIVITY PERIOD BE EXTENDED, AND AT WHAT COST? (2018) (0)
- Including Pharmaceuticals in Bundled Payments (2022) (0)
- Fairness in the trade-off between drug price regulation and investments in research and development: A survey of economists (2020) (0)
- Examining the Target Population of Orphan Drugs: Are Drugs Exceeding the Intended Purposes of The Orphan Drug Act? (2018) (0)
- Third World health: back to basics. (1982) (0)
- Special issue: International comparability of DRGs. (1991) (0)
- DataWatch Hospital Employment Trends In California , 1982-1994 by (2001) (0)
- Profitable Hospitals: The Authors Reply. (2016) (0)
- Incorrect Wording. (2017) (0)
- Health Affairs Different From Other Countries It ' s The Prices , Stupid : Why The United States Is So and (2003) (0)
- Developing Prioritization Criteria to Identify Target Drugs for CalRx the California Generic Drugs Initiative. (2022) (0)
- Frequency and Costs of Out-of-Network Bills for Outpatient Laboratory Services Among Privately Insured Patients. (2021) (0)
- Willingness to Follow Mask Mandates Increases Over Two-Month Period. (2021) (0)
- Are Physicians Appropriately Trained to Treat Chronic Conditions (2004) (0)
- Consolidated Drug Purchasing across Federal Agencies: A Solution to Improve Drug Affordability in Medicare Part D (2019) (0)
- Emergency/trauma care nursing. (1991) (0)
- Long-Term Growth Modeling of Healthcare Spending in OECD Countries, 1970-2004 (2007) (0)
- US Spending On Health Care: The Authors Reply. (2019) (0)
- Trustee Compensation And Charity Care Provision In US Nonprofit Hospitals. (2023) (0)
- Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019 (2022) (0)
- RE2 HOW MUCH COULD BE SAVED BY REQUIRING COMPANIES TO REFUND TAX INCENTIVES ON BLOCKBUSTER ORPHAN DRUGS (2020) (0)
- Defining the private versus the public sectors' roles in meeting this region's rising health care needs is a major challenge. (2008) (0)
- Measuring and Mitigating Gender-Based Disparities in Earning Potential in Academic Medicine. (2022) (0)
- An Effective Approach To Containing Costs In Japan , All-Payer Rate Setting Under Tight Government Control Has Proved To Be (2012) (0)
- The Association Between Drug Approvals and Burden of Disease From 1990 to 2017 (2021) (0)
- Quality improvement organizations and hospital care [1] (multiple letters) (2005) (0)
- U.S. and U.K. health spending [5] (multiple letters) (2005) (0)
- Unintended Consequences of Limiting Residents' Work Hours (2004) (0)
- Estimating Savings Opportunities From Therapeutic Substitutions of High-Cost Generic Medications (2022) (0)
- Older Americans' Preferences Between Lower Drug Prices and Prescription Drug Plan Choice, 2019. (2020) (0)
- Prospective payment for capital: An examination of current issues (1988) (0)
- Health Care Financing and Coverage in Central and Eastern Europe – Trends and Challenges (2008) (0)
- An Unexpected Conclusion: The Authors Respond (1996) (0)
- Price Variation for Total Shoulder Arthroplasty in the United States: Transparency, Variability, and Compliance with Federal Reporting Regulations (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gerard Fenton Anderson?
Gerard Fenton Anderson is affiliated with the following schools:
